Gene symbol: Bmp2

Organism: Rattus norvegicus

Summary: Enables growth factor activity; identical protein binding activity; and protein domain specific binding activity. Involved in several processes, including BMP signaling pathway; cellular response to mechanical stimulus; and response to retinoic acid. Acts upstream of or within positive regulation of neurogenesis and positive regulation of transcription by RNA polymerase II. Located in cytoplasm; extracellular space; and vesicle. Part of protein-containing complex. Human ortholog(s) of this gene implicated in bone disease (multiple); hemochromatosis type 1; otosclerosis; prostate cancer; and tooth agenesis. Orthologous to human BMP2 (bone morphogenetic protein 2). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 29373 Ensembl:ENSRNOG00000071010 AllianceGenome:RGD:2211


GO Annotation


Category Term ID Term description
Process GO:0000003 Reproduction
Process GO:0000122 Negative regulation of transcription by RNA polymerase II
Process GO:0001501 Skeletal system development
Process GO:0001503 Ossification
Process GO:0001649 Osteoblast differentiation
Process GO:0001655 Urogenital system development
Process GO:0001657 Ureteric bud development
Process GO:0001658 Branching involved in ureteric bud morphogenesis
Process GO:0001666 Response to hypoxia
Process GO:0001701 In utero embryonic development
Process GO:0001759 Organ induction
Process GO:0001763 Morphogenesis of a branching structure
Process GO:0001822 Kidney development
Process GO:0001823 Mesonephros development
Process GO:0001837 Epithelial to mesenchymal transition
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001933 Negative regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001936 Regulation of endothelial cell proliferation
Process GO:0001938 Positive regulation of endothelial cell proliferation
Process GO:0002009 Morphogenesis of an epithelium
Process GO:0002062 Chondrocyte differentiation
Process GO:0002065 Columnar/cuboidal epithelial cell differentiation
Process GO:0002067 Glandular epithelial cell differentiation
Process GO:0003002 Regionalization
Process GO:0003007 Heart morphogenesis
Process GO:0003129 Heart induction
Process GO:0003130 BMP signaling pathway involved in heart induction
Process GO:0003133 Endodermal-mesodermal cell signaling
Process GO:0003134 Endodermal-mesodermal cell signaling involved in heart induction
Process GO:0003156 Regulation of animal organ formation
Process GO:0003170 Heart valve development
Process GO:0003171 Atrioventricular valve development
Process GO:0003176 Aortic valve development
Process GO:0003179 Heart valve morphogenesis
Process GO:0003181 Atrioventricular valve morphogenesis
Process GO:0003197 Endocardial cushion development
Process GO:0003203 Endocardial cushion morphogenesis
Process GO:0003205 Cardiac chamber development
Process GO:0003206 Cardiac chamber morphogenesis
Process GO:0003207 Cardiac chamber formation
Process GO:0003209 Cardiac atrium morphogenesis
Process GO:0003210 Cardiac atrium formation
Process GO:0003230 Cardiac atrium development
Process GO:0003272 Endocardial cushion formation
Process GO:0003307 Regulation of Wnt signaling pathway involved in heart development
Process GO:0003308 Negative regulation of Wnt signaling pathway involved in heart development
Process GO:0003330 Regulation of extracellular matrix constituent secretion
Process GO:0003331 Positive regulation of extracellular matrix constituent secretion
Process GO:0006029 Proteoglycan metabolic process
Process GO:0006139 Nucleobase-containing compound metabolic process
Process GO:0006351 Transcription, DNA-templated
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006366 Transcription by RNA polymerase II
Process GO:0006468 Protein phosphorylation
Process GO:0006469 Negative regulation of protein kinase activity
Process GO:0006725 Cellular aromatic compound metabolic process
Process GO:0006793 Phosphorus metabolic process
Process GO:0006796 Phosphate-containing compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006950 Response to stress
Process GO:0006952 Defense response
Process GO:0006954 Inflammatory response
Process GO:0007154 Cell communication
Process GO:0007162 Negative regulation of cell adhesion
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007167 Enzyme-linked receptor protein signaling pathway
Process GO:0007178 Transmembrane receptor protein serine/threonine kinase signaling pathway
Process GO:0007219 Notch signaling pathway
Process GO:0007267 Cell-cell signaling
Process GO:0007275 Multicellular organism development
Process GO:0007389 Pattern specification process
Process GO:0007399 Nervous system development
Process GO:0007417 Central nervous system development
Process GO:0007420 Brain development
Process GO:0007423 Sensory organ development
Process GO:0007507 Heart development
Process GO:0007517 Muscle organ development
Process GO:0008152 Metabolic process
Process GO:0008283 Cell population proliferation
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008285 Negative regulation of cell population proliferation
Process GO:0009058 Biosynthetic process
Process GO:0009059 Macromolecule biosynthetic process
Process GO:0009100 Glycoprotein metabolic process
Process GO:0009605 Response to external stimulus
Process GO:0009607 Response to biotic stimulus
Process GO:0009612 Response to mechanical stimulus
Process GO:0009617 Response to bacterium
Process GO:0009628 Response to abiotic stimulus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009719 Response to endogenous stimulus
Process GO:0009790 Embryo development
Process GO:0009792 Embryo development ending in birth or egg hatching
Process GO:0009887 Animal organ morphogenesis
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009890 Negative regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009952 Anterior/posterior pattern specification
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009968 Negative regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010001 Glial cell differentiation
Process GO:0010033 Response to organic substance
Process GO:0010463 Mesenchymal cell proliferation
Process GO:0010467 Gene expression
Process GO:0010468 Regulation of gene expression
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010558 Negative regulation of macromolecule biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010563 Negative regulation of phosphorus metabolic process
Process GO:0010565 Regulation of cellular ketone metabolic process
Process GO:0010566 Regulation of ketone biosynthetic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010629 Negative regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010648 Negative regulation of cell communication
Process GO:0010717 Regulation of epithelial to mesenchymal transition
Process GO:0010718 Positive regulation of epithelial to mesenchymal transition
Process GO:0010720 Positive regulation of cell development
Process GO:0010817 Regulation of hormone levels
Process GO:0010862 Positive regulation of pathway-restricted SMAD protein phosphorylation
Process GO:0010894 Negative regulation of steroid biosynthetic process
Process GO:0010921 Regulation of phosphatase activity
Process GO:0010922 Positive regulation of phosphatase activity
Process GO:0010941 Regulation of cell death
Process GO:0010942 Positive regulation of cell death
Process GO:0014013 Regulation of gliogenesis
Process GO:0014015 Positive regulation of gliogenesis
Process GO:0014070 Response to organic cyclic compound
Process GO:0014706 Striated muscle tissue development
Process GO:0016055 Wnt signaling pathway
Process GO:0016070 RNA metabolic process
Process GO:0016310 Phosphorylation
Process GO:0017015 Regulation of transforming growth factor beta receptor signaling pathway
Process GO:0018130 Heterocycle biosynthetic process
Process GO:0019216 Regulation of lipid metabolic process
Process GO:0019218 Regulation of steroid metabolic process
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019438 Aromatic compound biosynthetic process
Process GO:0019538 Protein metabolic process
Process GO:0021536 Diencephalon development
Process GO:0021537 Telencephalon development
Process GO:0021700 Developmental maturation
Process GO:0021871 Forebrain regionalization
Process GO:0021978 Telencephalon regionalization
Process GO:0021983 Pituitary gland development
Process GO:0021984 Adenohypophysis development
Process GO:0022008 Neurogenesis
Process GO:0022407 Regulation of cell-cell adhesion
Process GO:0022408 Negative regulation of cell-cell adhesion
Process GO:0022414 Reproductive process
Process GO:0022603 Regulation of anatomical structure morphogenesis
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0023057 Negative regulation of signaling
Process GO:0030111 Regulation of Wnt signaling pathway
Process GO:0030154 Cell differentiation
Process GO:0030155 Regulation of cell adhesion
Process GO:0030177 Positive regulation of Wnt signaling pathway
Process GO:0030178 Negative regulation of Wnt signaling pathway
Process GO:0030278 Regulation of ossification
Process GO:0030282 Bone mineralization
Process GO:0030334 Regulation of cell migration
Process GO:0030335 Positive regulation of cell migration
Process GO:0030500 Regulation of bone mineralization
Process GO:0030501 Positive regulation of bone mineralization
Process GO:0030509 BMP signaling pathway
Process GO:0030512 Negative regulation of transforming growth factor beta receptor signaling pathway
Process GO:0030855 Epithelial cell differentiation
Process GO:0030856 Regulation of epithelial cell differentiation
Process GO:0030858 Positive regulation of epithelial cell differentiation
Process GO:0030900 Forebrain development
Process GO:0031128 Developmental induction
Process GO:0031214 Biomineral tissue development
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031324 Negative regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031327 Negative regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031399 Regulation of protein modification process
Process GO:0031400 Negative regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0031647 Regulation of protein stability
Process GO:0031648 Protein destabilization
Process GO:0031943 Regulation of glucocorticoid metabolic process
Process GO:0031944 Negative regulation of glucocorticoid metabolic process
Process GO:0031946 Regulation of glucocorticoid biosynthetic process
Process GO:0031947 Negative regulation of glucocorticoid biosynthetic process
Process GO:0032092 Positive regulation of protein binding
Process GO:0032147 Activation of protein kinase activity
Process GO:0032344 Regulation of aldosterone metabolic process
Process GO:0032345 Negative regulation of aldosterone metabolic process
Process GO:0032347 Regulation of aldosterone biosynthetic process
Process GO:0032348 Negative regulation of aldosterone biosynthetic process
Process GO:0032350 Regulation of hormone metabolic process
Process GO:0032351 Negative regulation of hormone metabolic process
Process GO:0032353 Negative regulation of hormone biosynthetic process
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032504 Multicellular organism reproduction
Process GO:0032526 Response to retinoic acid
Process GO:0032774 RNA biosynthetic process
Process GO:0032872 Regulation of stress-activated MAPK cascade
Process GO:0032874 Positive regulation of stress-activated MAPK cascade
Process GO:0032879 Regulation of localization
Process GO:0033673 Negative regulation of kinase activity
Process GO:0033674 Positive regulation of kinase activity
Process GO:0033688 Regulation of osteoblast proliferation
Process GO:0033690 Positive regulation of osteoblast proliferation
Process GO:0033993 Response to lipid
Process GO:0034641 Cellular nitrogen compound metabolic process
Process GO:0034654 Nucleobase-containing compound biosynthetic process
Process GO:0035051 Cardiocyte differentiation
Process GO:0035054 Embryonic heart tube anterior/posterior pattern specification
Process GO:0035239 Tube morphogenesis
Process GO:0035270 Endocrine system development
Process GO:0035295 Tube development
Process GO:0035303 Regulation of dephosphorylation
Process GO:0035306 Positive regulation of dephosphorylation
Process GO:0035358 Regulation of peroxisome proliferator activated receptor signaling pathway
Process GO:0035360 Positive regulation of peroxisome proliferator activated receptor signaling pathway
Process GO:0035630 Bone mineralization involved in bone maturation
Process GO:0036211 Protein modification process
Process GO:0036293 Response to decreased oxygen levels
Process GO:0036302 Atrioventricular canal development
Process GO:0036305 Ameloblast differentiation
Process GO:0040012 Regulation of locomotion
Process GO:0040017 Positive regulation of locomotion
Process GO:0042063 Gliogenesis
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042325 Regulation of phosphorylation
Process GO:0042326 Negative regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042475 Odontogenesis of dentin-containing tooth
Process GO:0042476 Odontogenesis
Process GO:0042481 Regulation of odontogenesis
Process GO:0042482 Positive regulation of odontogenesis
Process GO:0042487 Regulation of odontogenesis of dentin-containing tooth
Process GO:0042692 Muscle cell differentiation
Process GO:0042698 Ovulation cycle
Process GO:0042981 Regulation of apoptotic process
Process GO:0043009 Chordate embryonic development
Process GO:0043065 Positive regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043068 Positive regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043086 Negative regulation of catalytic activity
Process GO:0043170 Macromolecule metabolic process
Process GO:0043207 Response to external biotic stimulus
Process GO:0043393 Regulation of protein binding
Process GO:0043405 Regulation of MAP kinase activity
Process GO:0043407 Negative regulation of MAP kinase activity
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043409 Negative regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0043412 Macromolecule modification
Process GO:0043549 Regulation of kinase activity
Process GO:0043567 Regulation of insulin-like growth factor receptor signaling pathway
Process GO:0043569 Negative regulation of insulin-like growth factor receptor signaling pathway
Process GO:0043583 Ear development
Process GO:0043931 Ossification involved in bone maturation
Process GO:0044092 Negative regulation of molecular function
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044260 Cellular macromolecule metabolic process
Process GO:0044271 Cellular nitrogen compound biosynthetic process
Process GO:0044419 Biological process involved in interspecies interaction between organisms
Process GO:0045165 Cell fate commitment
Process GO:0045595 Regulation of cell differentiation
Process GO:0045596 Negative regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045598 Regulation of fat cell differentiation
Process GO:0045600 Positive regulation of fat cell differentiation
Process GO:0045664 Regulation of neuron differentiation
Process GO:0045666 Positive regulation of neuron differentiation
Process GO:0045667 Regulation of osteoblast differentiation
Process GO:0045669 Positive regulation of osteoblast differentiation
Process GO:0045685 Regulation of glial cell differentiation
Process GO:0045687 Positive regulation of glial cell differentiation
Process GO:0045778 Positive regulation of ossification
Process GO:0045786 Negative regulation of cell cycle
Process GO:0045833 Negative regulation of lipid metabolic process
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045860 Positive regulation of protein kinase activity
Process GO:0045892 Negative regulation of transcription, DNA-templated
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045934 Negative regulation of nucleobase-containing compound metabolic process
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045936 Negative regulation of phosphate metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045939 Negative regulation of steroid metabolic process
Process GO:0045944 Positive regulation of transcription by RNA polymerase II
Process GO:0046483 Heterocycle metabolic process
Process GO:0046885 Regulation of hormone biosynthetic process
Process GO:0046890 Regulation of lipid biosynthetic process
Process GO:0048511 Rhythmic process
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0048609 Multicellular organismal reproductive process
Process GO:0048644 Muscle organ morphogenesis
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048660 Regulation of smooth muscle cell proliferation
Process GO:0048662 Negative regulation of smooth muscle cell proliferation
Process GO:0048708 Astrocyte differentiation
Process GO:0048710 Regulation of astrocyte differentiation
Process GO:0048711 Positive regulation of astrocyte differentiation
Process GO:0048729 Tissue morphogenesis
Process GO:0048731 System development
Process GO:0048732 Gland development
Process GO:0048738 Cardiac muscle tissue development
Process GO:0048754 Branching morphogenesis of an epithelial tube
Process GO:0048762 Mesenchymal cell differentiation
Process GO:0048799 Animal organ maturation
Process GO:0048839 Inner ear development
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0050678 Regulation of epithelial cell proliferation
Process GO:0050679 Positive regulation of epithelial cell proliferation
Process GO:0050767 Regulation of neurogenesis
Process GO:0050769 Positive regulation of neurogenesis
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050810 Regulation of steroid biosynthetic process
Process GO:0050896 Response to stimulus
Process GO:0051040 Regulation of calcium-independent cell-cell adhesion
Process GO:0051042 Negative regulation of calcium-independent cell-cell adhesion
Process GO:0051046 Regulation of secretion
Process GO:0051047 Positive regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051055 Negative regulation of lipid biosynthetic process
Process GO:0051090 Regulation of DNA-binding transcription factor activity
Process GO:0051091 Positive regulation of DNA-binding transcription factor activity
Process GO:0051093 Negative regulation of developmental process
Process GO:0051094 Positive regulation of developmental process
Process GO:0051098 Regulation of binding
Process GO:0051099 Positive regulation of binding
Process GO:0051128 Regulation of cellular component organization
Process GO:0051130 Positive regulation of cellular component organization
Process GO:0051146 Striated muscle cell differentiation
Process GO:0051147 Regulation of muscle cell differentiation
Process GO:0051148 Negative regulation of muscle cell differentiation
Process GO:0051153 Regulation of striated muscle cell differentiation
Process GO:0051154 Negative regulation of striated muscle cell differentiation
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051216 Cartilage development
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051241 Negative regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051248 Negative regulation of protein metabolic process
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051253 Negative regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051338 Regulation of transferase activity
Process GO:0051345 Positive regulation of hydrolase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051348 Negative regulation of transferase activity
Process GO:0051707 Response to other organism
Process GO:0051716 Cellular response to stimulus
Process GO:0051726 Regulation of cell cycle
Process GO:0051960 Regulation of nervous system development
Process GO:0051962 Positive regulation of nervous system development
Process GO:0055007 Cardiac muscle cell differentiation
Process GO:0055008 Cardiac muscle tissue morphogenesis
Process GO:0060039 Pericardium development
Process GO:0060128 Corticotropin hormone secreting cell differentiation
Process GO:0060129 Thyroid-stimulating hormone-secreting cell differentiation
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060284 Regulation of cell development
Process GO:0060317 Cardiac epithelial to mesenchymal transition
Process GO:0060322 Head development
Process GO:0060348 Bone development
Process GO:0060389 Pathway-restricted SMAD protein phosphorylation
Process GO:0060390 Regulation of SMAD protein signal transduction
Process GO:0060391 Positive regulation of SMAD protein signal transduction
Process GO:0060393 Regulation of pathway-restricted SMAD protein phosphorylation
Process GO:0060395 SMAD protein signal transduction
Process GO:0060415 Muscle tissue morphogenesis
Process GO:0060429 Epithelium development
Process GO:0060485 Mesenchyme development
Process GO:0060537 Muscle tissue development
Process GO:0060562 Epithelial tube morphogenesis
Process GO:0060563 Neuroepithelial cell differentiation
Process GO:0060675 Ureteric bud morphogenesis
Process GO:0060804 Positive regulation of Wnt signaling pathway by BMP signaling pathway
Process GO:0060828 Regulation of canonical Wnt signaling pathway
Process GO:0060993 Kidney morphogenesis
Process GO:0061035 Regulation of cartilage development
Process GO:0061036 Positive regulation of cartilage development
Process GO:0061061 Muscle structure development
Process GO:0061101 Neuroendocrine cell differentiation
Process GO:0061138 Morphogenesis of a branching epithelium
Process GO:0061209 Cell proliferation involved in mesonephros development
Process GO:0061311 Cell surface receptor signaling pathway involved in heart development
Process GO:0061312 BMP signaling pathway involved in heart development
Process GO:0061326 Renal tubule development
Process GO:0061333 Renal tubule morphogenesis
Process GO:0061448 Connective tissue development
Process GO:0062012 Regulation of small molecule metabolic process
Process GO:0062014 Negative regulation of small molecule metabolic process
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070167 Regulation of biomineral tissue development
Process GO:0070169 Positive regulation of biomineral tissue development
Process GO:0070302 Regulation of stress-activated protein kinase signaling cascade
Process GO:0070304 Positive regulation of stress-activated protein kinase signaling cascade
Process GO:0070372 Regulation of ERK1 and ERK2 cascade
Process GO:0070374 Positive regulation of ERK1 and ERK2 cascade
Process GO:0070482 Response to oxygen levels
Process GO:0070848 Response to growth factor
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0070977 Bone maturation
Process GO:0071214 Cellular response to abiotic stimulus
Process GO:0071260 Cellular response to mechanical stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071363 Cellular response to growth factor stimulus
Process GO:0071407 Cellular response to organic cyclic compound
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071496 Cellular response to external stimulus
Process GO:0071695 Anatomical structure maturation
Process GO:0071704 Organic substance metabolic process
Process GO:0071772 Response to BMP
Process GO:0071773 Cellular response to BMP stimulus
Process GO:0071900 Regulation of protein serine/threonine kinase activity
Process GO:0071901 Negative regulation of protein serine/threonine kinase activity
Process GO:0071902 Positive regulation of protein serine/threonine kinase activity
Process GO:0072001 Renal system development
Process GO:0072006 Nephron development
Process GO:0072009 Nephron epithelium development
Process GO:0072028 Nephron morphogenesis
Process GO:0072073 Kidney epithelium development
Process GO:0072078 Nephron tubule morphogenesis
Process GO:0072080 Nephron tubule development
Process GO:0072088 Nephron epithelium morphogenesis
Process GO:0072111 Cell proliferation involved in kidney development
Process GO:0072132 Mesenchyme morphogenesis
Process GO:0072138 Mesenchymal cell proliferation involved in ureteric bud development
Process GO:0072163 Mesonephric epithelium development
Process GO:0072164 Mesonephric tubule development
Process GO:0072171 Mesonephric tubule morphogenesis
Process GO:0072359 Circulatory system development
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0080135 Regulation of cellular response to stress
Process GO:0090030 Regulation of steroid hormone biosynthetic process
Process GO:0090032 Negative regulation of steroid hormone biosynthetic process
Process GO:0090090 Negative regulation of canonical Wnt signaling pathway
Process GO:0090092 Regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
Process GO:0090100 Positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
Process GO:0090101 Negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
Process GO:0090287 Regulation of cellular response to growth factor stimulus
Process GO:0090304 Nucleic acid metabolic process
Process GO:0097659 Nucleic acid-templated transcription
Process GO:0104004 Cellular response to environmental stimulus
Process GO:0110110 Positive regulation of animal organ morphogenesis
Process GO:0110148 Biomineralization
Process GO:0110149 Regulation of biomineralization
Process GO:0110151 Positive regulation of biomineralization
Process GO:0198738 Cell-cell signaling by wnt
Process GO:1900744 Regulation of p38MAPK cascade
Process GO:1900745 Positive regulation of p38MAPK cascade
Process GO:1901135 Carbohydrate derivative metabolic process
Process GO:1901360 Organic cyclic compound metabolic process
Process GO:1901362 Organic cyclic compound biosynthetic process
Process GO:1901522 Positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901576 Organic substance biosynthetic process
Process GO:1901700 Response to oxygen-containing compound
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902532 Negative regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902679 Negative regulation of RNA biosynthetic process
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1902893 Regulation of miRNA transcription
Process GO:1902895 Positive regulation of miRNA transcription
Process GO:1902930 Regulation of alcohol biosynthetic process
Process GO:1902931 Negative regulation of alcohol biosynthetic process
Process GO:1903053 Regulation of extracellular matrix organization
Process GO:1903055 Positive regulation of extracellular matrix organization
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903507 Negative regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1903530 Regulation of secretion by cell
Process GO:1903532 Positive regulation of secretion by cell
Process GO:1903844 Regulation of cellular response to transforming growth factor beta stimulus
Process GO:1905072 Cardiac jelly development
Process GO:1905114 Cell surface receptor signaling pathway involved in cell-cell signaling
Process GO:1905207 Regulation of cardiocyte differentiation
Process GO:1905208 Negative regulation of cardiocyte differentiation
Process GO:1905222 Atrioventricular canal morphogenesis
Process GO:1905314 Semi-lunar valve development
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000027 Regulation of animal organ morphogenesis
Process GO:2000064 Regulation of cortisol biosynthetic process
Process GO:2000065 Negative regulation of cortisol biosynthetic process
Process GO:2000145 Regulation of cell motility
Process GO:2000147 Positive regulation of cell motility
Process GO:2000628 Regulation of miRNA metabolic process
Process GO:2000630 Positive regulation of miRNA metabolic process
Process GO:2000725 Regulation of cardiac muscle cell differentiation
Process GO:2000726 Negative regulation of cardiac muscle cell differentiation
Process GO:2000826 Regulation of heart morphogenesis
Process GO:2001141 Regulation of RNA biosynthetic process
Component GO:0005576 Extracellular region
Component GO:0005615 Extracellular space
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005886 Plasma membrane
Component GO:0005887 Integral component of plasma membrane
Component GO:0009986 Cell surface
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0031224 Intrinsic component of membrane
Component GO:0031226 Intrinsic component of plasma membrane
Component GO:0031982 Vesicle
Component GO:0032991 Protein-containing complex
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043235 Receptor complex
Component GO:0070724 BMP receptor complex
Component GO:0071944 Cell periphery
Component GO:0098796 Membrane protein complex
Component GO:0098797 Plasma membrane protein complex
Component GO:0098802 Plasma membrane signaling receptor complex
Component GO:0110165 Cellular anatomical entity
Function GO:0005102 Signaling receptor binding
Function GO:0005125 Cytokine activity
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0008047 Enzyme activator activity
Function GO:0008083 Growth factor activity
Function GO:0019207 Kinase regulator activity
Function GO:0019208 Phosphatase regulator activity
Function GO:0019209 Kinase activator activity
Function GO:0019211 Phosphatase activator activity
Function GO:0019887 Protein kinase regulator activity
Function GO:0019904 Protein domain specific binding
Function GO:0030234 Enzyme regulator activity
Function GO:0030295 Protein kinase activator activity
Function GO:0030545 Signaling receptor regulator activity
Function GO:0030546 Signaling receptor activator activity
Function GO:0033612 Receptor serine/threonine kinase binding
Function GO:0039706 Co-receptor binding
Function GO:0042802 Identical protein binding
Function GO:0043539 Protein serine/threonine kinase activator activity
Function GO:0046332 SMAD binding
Function GO:0048018 Receptor ligand activity
Function GO:0070696 Transmembrane receptor protein serine/threonine kinase binding
Function GO:0070700 BMP receptor binding
Function GO:0098772 Molecular function regulator activity

Pathway annotation


Category Term ID Term description
RCTM RNO-1474244 Extracellular matrix organization
RCTM RNO-1566948 Elastic fibre formation
RCTM RNO-162582 Signal Transduction
RCTM RNO-201451 Signaling by BMP
RCTM RNO-2129379 Molecules associated with elastic fibres
RCTM RNO-9006936 Signaling by TGFB family members
WikiPathways WP155 Adipogenesis
WikiPathways WP397 ID signaling pathway
KEGG rno04060 Cytokine-cytokine receptor interaction
KEGG rno04350 TGF-beta signaling pathway
KEGG rno04390 Hippo signaling pathway
KEGG rno05200 Pathways in cancer
KEGG rno05217 Basal cell carcinoma

Expression profile of Bmp2 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 7.171253
GSM2685202 MX2 tissue: Myocardium gender: female 7.1292458
GSM2685203 MX3 tissue: Myocardium gender: female 7.375471
GSM2685204 MX4 tissue: Myocardium gender: male 7.461691
GSM2685205 DZ1 tissue: Myocardium gender: male 7.278997
GSM2685206 DZ2 tissue: Myocardium gender: male 7.1292458
GSM2685207 DZ3 tissue: Myocardium gender: female 7.423556
GSM2685208 DZ4 tissue: Myocardium gender: female 7.4824276
GSM2685209 JJ1 tissue: Myocardium gender: male 7.053795
GSM2685210 JJ2 tissue: Myocardium gender: female 7.1645803
GSM2685211 JJ3 tissue: Myocardium gender: female 7.5805845
GSM2685212 JJ4 tissue: Myocardium gender: male 7.370269
GSM2685213 NG1 tissue: Myocardium gender: male 7.758658
GSM2685214 NG2 tissue: Myocardium gender: female 7.1463766
GSM2685215 NG3 tissue: Myocardium gender: male 7.448167
GSM2685216 NG4 tissue: Myocardium gender: female 7.6902475
GSM2685217 YL1 tissue: Myocardium gender: male 7.295417
GSM2685218 YL2 tissue: Myocardium gender: male 7.7879486
GSM2685219 YL3 tissue: Myocardium gender: female 7.625813
GSM2685220 YL4 tissue: Myocardium gender: female 7.5282936
GSM2685221 QC1 tissue: Myocardium gender: male 7.5355554
GSM2685222 QC2 tissue: Myocardium gender: male 7.44786
GSM2685223 QC3 tissue: Myocardium gender: female 7.769699
GSM2685224 QC4 tissue: Myocardium gender: female 7.595408

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.535001993
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.571773716
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.483454737
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.42219856
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.652938773
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.524848396

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 74.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 56.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 217.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 47.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 95.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 92.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 140.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 192.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 53.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 63.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 64.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 160.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 66.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 85.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 72.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 100.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.1803
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.492098
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.318376
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.493169
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.339955
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.25653

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 0.871
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 0.764
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 1.186
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 0.908
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 1.036

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 6.6891061149999995
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 6.747774398000001
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 7.1099158435

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 57.95
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 55.2
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 62.55
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 45.65
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 50.7
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 38.45
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 73.25
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 93.85
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 64.15
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 27.299999999999997
GSM27494 CTL_a (control, 1st replicate) 31.9
GSM27495 CTL_b (control, 2nd replicate) 87.8
GSM27496 CTL_c (control, 3rd replicate) 88.55
GSM27497 CTL_d (control, 4th replicate) 76.30000000000001
GSM27498 CTL_e (control, 5th replicate) 69.5
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 47.3
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 59.900000000000006
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 46.599999999999994
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 81.45
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 72.05
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 114.1
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 97.8
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 30.5
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 128.85
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 25.8
GSM27509 ISCH_a (ischemia, 1st replicate) 84.8
GSM27510 ISCH_b (ischemia, 2nd replicate) 52.55
GSM27511 ISCH_c (ischemia, 3rd replicate) 57.35
GSM27512 ISCH_d (ischemia, 4th replicate) 82.65
GSM27513 ISCH_e (ischemia, 5th replicate) 54.25

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 85.45
GSM30791 baseline control 02 male, 275-300g 159.75
GSM30792 baseline control 03 male, 275-300g 122.55
GSM30793 baseline control 04 male, 275-300g 63.55
GSM30794 baseline control 05 male, 275-300g 113.95
GSM30795 baseline control 06 male, 275-300g 71.7
GSM30796 baseline control 07 male, 275-300g 79.15
GSM30797 baseline control 08 male, 275-300g 59.55
GSM30798 baseline control 09 male, 275-300g 85.55
GSM30799 pain 01 110.3
GSM30800 pain 02 128.7
GSM30801 pain 03 134.9
GSM30802 pain 04 95.4
GSM30803 pain 05 75.65
GSM30804 FC 01 97.4
GSM30805 FC 02 69.95
GSM30806 FC 03 72.05
GSM30807 FC 04 128.55
GSM30808 FC 05 94.6
GSM30809 IFC 01 83.64999999999999
GSM30810 IFC 02 119.1
GSM30811 IFC 03 107.89999999999999
GSM30812 IFC 04 95.55
GSM30813 IFC 05 100.65
GSM99800 isoflurane 01 male, 275-300g 66.3
GSM99801 isoflurane 02 male, 275-300g 98.2
GSM99802 isoflurane 03 male, 275-300g 123.75
GSM99803 isoflurane 04 male, 275-300g 90.25
GSM99804 isoflurane 05 male, 275-300g 119.4

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 27.89035
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 35.2716
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 45.70265
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 33.57985
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 23.6468
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 35.48175
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 40.13945
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 35.41905
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 34.859899999999996

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 5.93576
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 6.43681
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 6.17692
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 7.25235
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 4.57522
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 5.34663
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 5.61341
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 5.63823
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 5.40293
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 4.73916
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 6.17977
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 6.5125
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 3.79373
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 3.80502
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 4.84601
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 3.89133

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.57888
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.564282
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.770976
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.748525
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.592493
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.154009
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.062787
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.418104
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.147569
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.047428
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 8.341561
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 8.456218
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 8.511424
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 8.284945
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 8.375402
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.216843
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.490254
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.265322
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.462696
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.204238
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.362056
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.234496
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.417725
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.276489
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.429748
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.885456
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 8.041519
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 8.014992
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 8.165451
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 8.127613
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.439873
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.677465
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.511523
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.55978
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.14767
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.278011
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.7883
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.559727
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.433796
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.363714
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.017811
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.892458
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.191169
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.975745
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.871665

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 4.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 7.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 7.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 8.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 2.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 1.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 10.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 8.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 4.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 12.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 0.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 3.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 3.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 10.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 3.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 4.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 6.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 8.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 11.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 4.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 5.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 5.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 3.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 10.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 2.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 0.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 7.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 7.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 8.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 7.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 4.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 8.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 6.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 4.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 6.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 3.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 13.297021
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 15.015262
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 14.109138
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 16.388611

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; 0.254
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.132
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 -0.0388
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.0237
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 0.0915
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 0.201
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 0.135
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 -0.0296
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.0396
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 -0.163
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.146
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 -0.0762

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 7.75
GSM5121 Isoflurane single exposure control-2 7.0
GSM5122 Isoflurane single exposure control-3 16.85
GSM5124 Isoflurane single exposure 1 hr-1 14.3
GSM5126 Isoflurane single exposure 1 hr-2 10.6
GSM5127 Isoflurane single exposure 2 hr-1 5.25
GSM5130 Isoflurane single exposure 2 hr-2 7.6499999999999995
GSM5131 Isoflurane single exposure 2 hr-3 4.050000000000001

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.9344143845
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.8406805889999998
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.7234219525
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.8141980665
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.9436730349999998
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.559317292499999
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.8656975
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.6413849535
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.3475886515
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.8290958405
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.9723959539999996
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.5609235505
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.751774184
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.3749364105
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.821819703
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.8599603125
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.8623724905000003
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.107169254
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.6644418315
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.066709855
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.9688260735000003
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.0307777885
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.3509386725
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.805823043

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.963792
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.818427
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.880249
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.801553
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.879449
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.817848
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.864717
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.974687
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.961795
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.729903
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.837737
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.824825
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.816125
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.828308
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.821222
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.722694
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.854633
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.835958
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.802433
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.748845
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.836767
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.780505
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.880089
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.799692

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 142.8229
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 164.3681

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 47.110508415
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 31.219748549
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 106.115938235
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 39.451350815
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 54.690260385
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 90.468141065
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 23.541773204000002
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 80.70016179999999
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 6.719304367
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 39.83755582
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 27.1484588
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 83.11751662
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 52.35221013
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 193.41005944

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.9344143845
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.8406805889999998
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.7234219525
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.8141980665
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.9436730349999998
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.559317292499999
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.8656975
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.6413849535
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.3475886515
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.8290958405
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.9723959539999996
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.5609235505
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.751774184
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.3749364105
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.821819703
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.8599603125
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 3.8623724905000003
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.107169254
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.6644418315
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.066709855
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.9688260735000003
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.0307777885
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.3509386725
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.805823043
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 47.110508415
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 31.219748549
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 106.115938235
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 39.451350815
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 54.690260385
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 90.468141065
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 23.541773204000002
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 80.70016179999999
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 6.719304367
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 39.83755582
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 27.1484588
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 83.11751662
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 52.35221013
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 193.41005944

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 5.4
GSM5084 Control 2 7.800000000000001
GSM5085 Control 3 15.5
GSM5086 Control 4 8.85
GSM5087 Control 5 10.549999999999999
GSM5090 Control 6 12.1
GSM5105 Control 7 10.450000000000001
GSM5106 Control 8 4.0
GSM5107 Control 9 9.3
GSM5108 Halothane 10 exposure-1 5.449999999999999
GSM5109 Halothane 10 exposures-2 7.4
GSM5110 Halothane 10 exposures-3 8.4
GSM5111 Halothane 5 exposures-1 8.45
GSM5112 Halothane 5 exposures-2 6.3500000000000005
GSM5113 Halothane 5 exposures-3 13.75
GSM5114 Isoflurane 10 exposures-1 8.5
GSM5115 Isoflurane 10 exposures-2 19.3
GSM5116 Isoflurane 10 exposures-3 9.1
GSM5117 Isoflurane 5 exposures-1 11.4
GSM5118 Isoflurane 5 exposures-2 10.85
GSM5119 Isoflurane 5 exposures-3 15.0
GSM11379 Control 10 7.9
GSM11380 Control 11 8.3
GSM11381 Control 12 9.7

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 22.828799999999998
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 15.329915